Short-term outcomes of bariatric surgery in patients with inflammatory bowel disease: a national analysis.

ABSTRACT

BACKGROUND: While considered standard of care for obesity management, bariatric surgery is uncommon in patients with co-morbid inflammatory bowel disease (IBD). OBJECTIVES: The present study aimed to assess the association of IBD with postoperative outcomes and resource use following bariatric surgery. SETTING: Academic, university-affiliated; United States. METHODS: All elective adult hospitalizations for laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass (RYGB) were identified in the 2016-2019 Nationwide Readmissions Database. Patients were classified based on diagnosis of ulcerative colitis (UC) or Crohn's disease (CD). Multivariable regression models were developed to evaluate the association of IBD with outcomes of interest. RESULTS: Of an estimated 719,270 eligible patients, 860 and 1214 comprised the UC and CD cohorts, respectively. Compared to non-IBD, UC and CD had a higher Elixhauser comorbidity index (UC 3.0 ± 1.4; CD 3.1 ± 1.5; non-IBD 2.7 ± 1.4, P < .001) and more frequently underwent sleeve gastrectomy (UC 77.5%; CD 83.2%; non-IBD 68.8%, P < .001). All IBD patients survived to discharge. After adjustment, IBD was not associated with significant differences in most clinical outcomes analyzed. UC (adjusted odds ratio 2.86; 95% confidence interval 1.14-7.13) and CD (adjusted odds ratio 4.40; 95% confidence interval 2.20-8.80) were associated with increased odds of gastric outlet obstruction after RYGB but not sleeve gastrectomy. CD, but not UC, was linked to significantly higher odds of small bowel obstruction following RYGB (adjusted odds ratio 4.50; 95% confidence interval 1.76-11.49). There was no difference in index LOS, hospitalization costs, or odds of 30-day readmission based on IBD. CONCLUSIONS: Patients with obesity and IBD faced low rates of adverse outcomes following bariatric surgery. There is an increased risk of gastrointestinal obstruction for patients with IBD undergoing RYGB. Given its safety profile, bariatric surgery can be utilized as a weight loss intervention for the growing proportion of patients with obesity and co-morbid IBD.